A detailed history of Mittelman Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Mittelman Wealth Management holds 12,016 shares of PFE stock, worth $328,757. This represents 0.22% of its overall portfolio holdings.

Number of Shares
12,016
Previous 7,850 53.07%
Holding current value
$328,757
Previous $218 Million 54.34%
% of portfolio
0.22%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $105,233 - $123,313
4,166 Added 53.07%
12,016 $336 Million
Q1 2024

May 06, 2024

BUY
$25.89 - $29.73 $203,236 - $233,380
7,850 New
7,850 $218 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mittelman Wealth Management Portfolio

Follow Mittelman Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mittelman Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Mittelman Wealth Management with notifications on news.